By expenditures
| Name | Title | Type |
|---|---|---|
| Jennifer Barclay | Finance Director | Auditee |
| Andrea Caladie | Principal | Auditee |
| Jeffrey Weiss | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 344853 | 2023 | 2025-03-05 | Zelenkofske Axelrod LLC | $20.02M |
| 292829 | 2022 | 2024-02-29 | Baker Tilly US LLP | $30.67M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 344853 | 2023 | 2025-03-05 | 1102148 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102147 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102146 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102145 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102144 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102143 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102142 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102141 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102140 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102139 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 1102138 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525706 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525705 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525704 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525703 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525702 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525701 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525700 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525699 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525698 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525697 | 2023-003 | Significant Deficiency | Yes | L |
| 344853 | 2023 | 2025-03-05 | 525696 | 2023-003 | Significant Deficiency | Yes | L |
| 292829 | 2022 | 2024-02-29 | 947626 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947625 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947624 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947623 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947622 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947621 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947620 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947619 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947618 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 947617 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371184 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371183 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371182 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371181 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371180 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371179 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371178 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371177 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371176 | 2022-003 | Significant Deficiency | - | L |
| 292829 | 2022 | 2024-02-29 | 371175 | 2022-003 | Significant Deficiency | - | L |